Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like FT News Briefing →
Pfizer Under Fire and an Alibaba Beatdown
China's race to tech supremacy: Driving into Europe
It’s bean difficult: the China-America trade war
Big deals in Big Pharma
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.